Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Year-over-year debt growth rate
Latest
-4.24%
↓ 103% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
131.17%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -4.24% |
| Q3 2025 | -94.68% |
| Q2 2025 | -0.05% |
| Q1 2025 | -0.06% |
| Q4 2024 | 1644.01% |
| Q3 2024 | 923.31% |
| Q2 2024 | -14.70% |
| Q1 2024 | -13.90% |
| Q4 2023 | -14.26% |
| Q3 2023 | -3.09% |
| Q2 2023 | 1143.59% |
| Q1 2023 | -74.84% |
| Q4 2022 | -35.15% |
| Q3 2022 | -29.08% |
| Q2 2022 | -20.33% |
| Q1 2022 | -7.44% |
| Q4 2021 | -18.97% |
| Q3 2021 | 2.17% |
| Q2 2021 | 868.42% |
| Q1 2021 | -58.99% |
| Q4 2020 | -36.82% |
| Q3 2020 | -26.17% |
| Q2 2020 | -5.40% |
| Q1 2020 | 3.28% |
| Q4 2019 | 1120.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |